Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT03708822 · UNKNOWN
Trial details
- NCT number
- NCT03708822
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2022-07-20
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.